Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

GB263T

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Walvax

Drug class:

EGFR inhibitor, c-MET inhibitor

Related drugs:

‹

EMD 1204831 (0)

PF-04217903 (0)

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

aumolertinib (39)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

zorifertinib (3)

ABP 494 (cetuximab biosimilar) (1)

BAY 2927088 (1)

Compound 6a (1)

abivertinib (1)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

PF-08046052 (0)

rindopepimut (0)

Undisclosed EGFR inhibitor (0)

cetuximab biosimilar (0)

PF-06747775 (0)

JNJ-64041757 (0)

savolitinib (29)

capmatinib (23)

unecritinib (6)

gumarontinib (5)

JNJ-38877605 (1)

EMD 1204831 (0)

PF-04217903 (0)

›

EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	GB263T Sensitive: C3 – Early Trials GB263T Sensitive : C3	GB263T Sensitive: C3 – Early Trials GB263T Sensitive : C3
MET exon 14 mutation	Non Small Cell Lung Cancer	MET exon 14 mutation	Non Small Cell Lung Cancer	GB263T Sensitive: D – Preclinical GB263T Sensitive : D	GB263T Sensitive: D – Preclinical GB263T Sensitive : D
MET amplification	Non Small Cell Lung Cancer	MET amplification	Non Small Cell Lung Cancer	GB263T Sensitive: D – Preclinical GB263T Sensitive : D	GB263T Sensitive: D – Preclinical GB263T Sensitive : D
EGFR C797S	Non Small Cell Lung Cancer	EGFR C797S	Non Small Cell Lung Cancer	GB263T Sensitive: D – Preclinical GB263T Sensitive : D	GB263T Sensitive: D – Preclinical GB263T Sensitive : D
EGFR exon 20 insertion	Non Small Cell Lung Cancer	EGFR exon 20 insertion	Non Small Cell Lung Cancer	GB263T Sensitive: D – Preclinical GB263T Sensitive : D	GB263T Sensitive: D – Preclinical GB263T Sensitive : D